Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Biomaterials. 2013 Oct 19;35(2):699–710. doi: 10.1016/j.biomaterials.2013.10.018

Table 1.

List of antibodies used in staining, flow cytometry and western blot for various experiments.

Primary antibodies
Antigen Type Provider (Cat#) (lot#) Application
Nkx2.1 Rabbit polyclonal Abcam (Cat# ab76013, Lot# GR76790-2) ICC, IHC, FC
proSPB Rabbit polyclonal Millipore (Cat# ab3430, Lot# NG1820771) ICC, FC
proSPC Rabbit monoclonal Millipore (Cat# ab3786, Lot# 2117989) ICC, IHC, FC
SPA Rabbit polyclonal Millipore (Cat# ab3420, Lot# NG1888873) ICC
SPC Rabbit polyclonal Santa Cruz (Cat# sc-13979, Lot# L1710) ICC, IHC, FC
T1α Monoclonal Abcam (Cat# ab10288, Lot# GR47830-3) IHC
AQ5 Rabbit polyclonal Abcam(Cat# ab18530) ICC
Caveolin-1 Rabbit monoclonal Millipore(Cat#MAB4381, Lot# LV1512392) ICC
CD54-PE Mouse monoclonal BD Pharmingen (Cat# 560971, Lot# 10609) FC
Detection antibodies
Type Provider (Cat#) (lot#) Application
Alexa Fluor® 555 goat anti-rabbit IgG (H+L), highly cross-absorbed Invitrogen (Cat# A21429, Lot# 1010124) ICC, IHC
Alexa Fluor® 488 goat anti-rabbit IgG (H+L), highly cross-adsorbed Invitrogen (Cat# A11034, Lot# 1008720) ICC, IHC
Alexa Fluor® 555 goat anti-mouse IgG (H+L), highly cross-adsorbed Invitrogen (Cat# A21424, Lot# 1214852) ICC, IHC
APC Mouse IgG2a, κ isotype control BD Pharmingen (Cat# 555576, Lot# 33828) Isotype control
PE Mouse IgG1, κ isotype control eBiosciences (Cat# 12-4714-82, Lot# E01672-1630) Isotype control
Mouse IgG2a, κ isotype control FTIC– eBiosciences (Cat# 11-4724-81, Lot# E00590-1630) Isotype control
Isotype FITC goat anti mouse Ig (Cat# 611233, Lot# 039557)
PE mouse IgG κ isotype control (Cat# 555749, Lot# 38193)

Abbreviations: IHC, immunohistochemistry; ICC, immunocytochemistry; FC, flow cytometry; PE, phycoerythrin, APC, allophycocyanin; FITC, fluorescein isothiocyanate; SPA, surfactant protein A; SPB, surfactant protein B; SPC, surfactant protein C; Nkx2.1, NK2 homeobox 1.

HHS Vulnerability Disclosure